https://www.pharmacytimes.com/view/rollout-of-long-acting-cabotegravir-without-delay-can-have-greatest-impact-on-hiv-prep
Investigators said pre-exposure prophylaxis rollout is efficient in settings with high HIV incidence, but not in settings with low HIV incidence.
Create an account or login to join the discussion